Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Chapman

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Gastroenterology|March 27, 2022
Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?Joana Revés, Thomas P Chapman, Jack Satsangi, et al.
Gastroenterology|October 20, 2012
An unusual cause of chest painThomas P Chapman, David A Gorard, Emily A Johns
Frontline Gastroenterology|October 19, 2023
Caecal surpriseUmang Rafiq Qazi, Thomas P Chapman, Peter John Basford
Gastroenterology|September 16, 2021
Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?Thomas P Chapman, Joana Revés, Joana Torres, et al.
Journal of Crohn'S & Colitis|January 3, 2021
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021Vipin Gupta, Waled Mohsen, Thomas P Chapman, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
De-escalation of immunomodulator and biological therapy in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2020
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' replyThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Alimentary Pharmacology & Therapeutics|May 27, 2020
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Therapeutic Advances in Gastroenterology|November 13, 2023
Endoscopic characterization of neoplastic and non-neoplastic lesions in inflammatory bowel disease: systematic review in the era of advanced endoscopic imagingAndrea Cassinotti, Marco Parravicini, Thomas P Chapman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Unexplained gastrointestinal symptoms: think mitochondrial diseaseThomas P Chapman, Gina Hadley, Carl Fratter, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Gastroenterology|March 27, 2022
Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease-One Step Closer to Precision Medicine?Joana Revés, Thomas P Chapman, Jack Satsangi, et al.
Gastroenterology|October 20, 2012
An unusual cause of chest painThomas P Chapman, David A Gorard, Emily A Johns
Frontline Gastroenterology|October 19, 2023
Caecal surpriseUmang Rafiq Qazi, Thomas P Chapman, Peter John Basford
Gastroenterology|September 16, 2021
Anti-SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?Thomas P Chapman, Joana Revés, Joana Torres, et al.
Journal of Crohn'S & Colitis|January 3, 2021
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021Vipin Gupta, Waled Mohsen, Thomas P Chapman, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
De-escalation of immunomodulator and biological therapy in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2020
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' replyThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Alimentary Pharmacology & Therapeutics|May 27, 2020
Review article: withdrawal of 5-aminosalicylates in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Therapeutic Advances in Gastroenterology|November 13, 2023
Endoscopic characterization of neoplastic and non-neoplastic lesions in inflammatory bowel disease: systematic review in the era of advanced endoscopic imagingAndrea Cassinotti, Marco Parravicini, Thomas P Chapman, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Unexplained gastrointestinal symptoms: think mitochondrial diseaseThomas P Chapman, Gina Hadley, Carl Fratter, et al.
Pageof 3